Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-21-001022
Filing Date
2021-03-18
Accepted
2021-03-18 21:21:51
Documents
1
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es210138079_3-clfinch.html 3  
1 OWNERSHIP DOCUMENT es210138079_3-clfinch.xml 3 1501
  Complete submission text file 0000950142-21-001022.txt   2852
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

EIN.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 28 HAVEMEYER PLACE GREENWICH CT 06830
Business Address
Lange Christian H. (Reporting) CIK: 0001850652 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40227 | Film No.: 21756294